Growth Metrics

Soleno Therapeutics (SLNO) Other Non-Current Assets: 2014-2019

Historic Other Non-Current Assets for Soleno Therapeutics (SLNO) over the last 3 years, with Sep 2019 value amounting to $59,000.

  • Soleno Therapeutics' Other Non-Current Assets fell 93.03% to $59,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $59,000, marking a year-over-year decrease of 93.03%. This contributed to the annual value of $516,000 for FY2017, which is 67.67% down from last year.
  • Latest data reveals that Soleno Therapeutics reported Other Non-Current Assets of $59,000 as of Q3 2019, which was down 93.03% from $847,000 recorded in Q3 2018.
  • In the past 5 years, Soleno Therapeutics' Other Non-Current Assets registered a high of $2.3 million during Q2 2017, and its lowest value of $59,000 during Q3 2019.
  • In the last 3 years, Soleno Therapeutics' Other Non-Current Assets had a median value of $500,000 in 2017 and averaged $673,500.
  • As far as peak fluctuations go, Soleno Therapeutics' Other Non-Current Assets surged by 2,956.58% in 2017, and later crashed by 93.03% in 2019.
  • Quarterly analysis of 5 years shows Soleno Therapeutics' Other Non-Current Assets stood at $718,003 in 2015, then spiked by 122.28% to $1.6 million in 2016, then plummeted by 67.67% to $516,000 in 2017, then spiked by 50.44% to $847,000 in 2018, then crashed by 93.03% to $59,000 in 2019.
  • Its Other Non-Current Assets was $59,000 in Q3 2019, compared to $847,000 in Q3 2018 and $470,000 in Q2 2018.